Alexion Pharmaceuticals
Andrew Thistle is an experienced marketing and commercial leader in the pharmaceutical industry, currently serving as Associate Director of US Marketing for gMG at Alexion Pharmaceuticals, Inc. since October 2022. Prior to this role, Andrew held various positions at Biogen, including Senior Product Manager for the Interferon Franchise and completing a comprehensive Commercial Leadership Development Program with several rotations. Andrew's foundational experience in engineering began at ConforMIS, Inc., where significant contributions included leading product launches and designing medical instruments. With an MBA from Carnegie Mellon University's Tepper School of Business and a Bachelor's degree in Bioengineering from Union College, Andrew combines strategic marketing expertise with a strong technical background.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.